These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30846352)

  • 1. Glycemic control and complications in glycogen storage disease type I: Results from the Swiss registry.
    Kaiser N; Gautschi M; Bosanska L; Meienberg F; Baumgartner MR; Spinas GA; Hochuli M
    Mol Genet Metab; 2019 Apr; 126(4):355-361. PubMed ID: 30846352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous glucose monitoring in children with glycogen storage disease type I.
    Kasapkara ÇS; Cinasal Demir G; Hasanoğlu A; Tümer L
    Eur J Clin Nutr; 2014 Jan; 68(1):101-5. PubMed ID: 24149443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Prospective Study on Continuous Glucose Monitoring in Glycogen Storage Disease Type Ia: Toward Glycemic Targets.
    Rossi A; Venema A; Haarsma P; Feldbrugge L; Burghard R; Rodriguez-Buritica D; Parenti G; Oosterveer MH; Derks TGJ
    J Clin Endocrinol Metab; 2022 Aug; 107(9):e3612-e3623. PubMed ID: 35786777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of continuous glucose therapy begun in infancy on the long-term clinical course of patients with type I glycogen storage disease.
    Wolfsdorf JI; Crigler JF
    J Pediatr Gastroenterol Nutr; 1999 Aug; 29(2):136-43. PubMed ID: 10435649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose-6-phosphatase deficiency.
    Froissart R; Piraud M; Boudjemline AM; Vianey-Saban C; Petit F; Hubert-Buron A; Eberschweiler PT; Gajdos V; Labrune P
    Orphanet J Rare Dis; 2011 May; 6():27. PubMed ID: 21599942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disturbed sphingolipid metabolism with elevated 1-deoxysphingolipids in glycogen storage disease type I - A link to metabolic control.
    Hornemann T; Alecu I; Hagenbuch N; Zhakupova A; Cremonesi A; Gautschi M; Jung HH; Meienberg F; Bilz S; Christ E; Baumgartner MR; Hochuli M
    Mol Genet Metab; 2018 Sep; 125(1-2):73-78. PubMed ID: 30037504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I.
    Mathis T; Poms M; Köfeler H; Gautschi M; Plecko B; Baumgartner MR; Hochuli M
    J Inherit Metab Dis; 2022 Mar; 45(2):235-247. PubMed ID: 34671989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study.
    Hochuli M; Christ E; Meienberg F; Lehmann R; Krützfeldt J; Baumgartner MR
    J Inherit Metab Dis; 2015 Nov; 38(6):1093-8. PubMed ID: 26109257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous glucose monitoring in children with glycogen storage disease type I.
    Hershkovitz E; Rachmel A; Ben-Zaken H; Phillip M
    J Inherit Metab Dis; 2001 Dec; 24(8):863-9. PubMed ID: 11916320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sleep and quality of life of patients with glycogen storage disease on standard and modified uncooked cornstarch.
    Rousseau-Nepton I; Huot C; Laforte D; Mok E; Fenyves D; Constantin E; Mitchell J
    Mol Genet Metab; 2018 Mar; 123(3):326-330. PubMed ID: 29223626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation.
    Melis D; Rossi A; Pivonello R; Salerno M; Balivo F; Spadarella S; Muscogiuri G; Casa RD; Formisano P; Andria G; Colao A; Parenti G
    Orphanet J Rare Dis; 2015 Jul; 10():91. PubMed ID: 26219379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary exacerbation of metabolic stress leads to accelerated hepatic carcinogenesis in glycogen storage disease type Ia.
    Gjorgjieva M; Calderaro J; Monteillet L; Silva M; Raffin M; Brevet M; Romestaing C; Roussel D; Zucman-Rossi J; Mithieux G; Rajas F
    J Hepatol; 2018 Nov; 69(5):1074-1087. PubMed ID: 30193922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perioperative management of benign hepatic tumors in patients with glycogen storage disease type Ia.
    Oshita A; Itamoto T; Amano H; Ohdan H; Tashiro H; Asahara T
    J Hepatobiliary Pancreat Surg; 2008; 15(2):200-3. PubMed ID: 18392715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood glucose trends in glycogen storage disease type Ia: A cross-sectional study.
    Fukuda T; Ito T; Hamazaki T; Inui A; Ishige M; Kagawa R; Sakai N; Watanabe Y; Kobayashi H; Wasaki Y; Taura J; Imamura Y; Tsukiuda T; Nakamura K
    J Inherit Metab Dis; 2023 Jul; 46(4):618-633. PubMed ID: 37114839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adult male patient with multiple adenomas and a hepatocellular carcinoma: mild glycogen storage disease type Ia.
    Cassiman D; Libbrecht L; Verslype C; Meersseman W; Troisi R; Zucman-Rossi J; Van Vlierberghe H
    J Hepatol; 2010 Jul; 53(1):213-7. PubMed ID: 20447711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of continuous glucose monitoring in the management of glycogen storage disorders.
    Herbert M; Pendyal S; Rairikar M; Halaby C; Benjamin RW; Kishnani PS
    J Inherit Metab Dis; 2018 Nov; 41(6):917-927. PubMed ID: 29802555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The application of continuous glucose monitoring in the management of hepatic glycogen storage disease].
    Du CQ; Wei H; Zhang C; Zhang M; Hu MH; Hou L; Wu W; Liang Y; Luo XP
    Zhonghua Er Ke Za Zhi; 2021 Jun; 59(6):452-458. PubMed ID: 34102817
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycogen Storage Disease Type Ia: Current Management Options, Burden and Unmet Needs.
    Derks TGJ; Rodriguez-Buritica DF; Ahmad A; de Boer F; Couce ML; Grünert SC; Labrune P; López Maldonado N; Fischinger Moura de Souza C; Riba-Wolman R; Rossi A; Saavedra H; Gupta RN; Valayannopoulos V; Mitchell J
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and reversed growth retardation in a child with type Ia glycogen storage disease.
    Karnsakul W; Gillespie S; Skitarelic K; Hummel M
    J Pediatr Endocrinol Metab; 2010 May; 23(5):507-12. PubMed ID: 20662351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of glycogen storage disease type I on adult daily life: a survey.
    Garbade SF; Ederer V; Burgard P; Wendel U; Spiekerkoetter U; Haas D; Grünert SC
    Orphanet J Rare Dis; 2021 Sep; 16(1):371. PubMed ID: 34479584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.